Devoted Health: $12.6B valuation, IPO Readiness 66, Series E. Medicare Advantage plan combining insurance and care coordination for seniors. Track live on The IPO Stack.
Medicare Advantage plan combining insurance and care coordination for seniors.
Scores, valuations, and IPO signals for the companies that matter. 5-minute read, every Tuesday.
Top companies most likely to IPO in 2026, ranked by IPO Readiness Score.
Track Devoted Health IPO timeline, funding rounds, investor activity, and valuation on TechStackIPO — the pre-IPO intelligence platform.
Devoted Health has not announced a specific IPO date as of 2026. Track TechStackIPO for the latest funding milestones and IPO signals. Subscribe to The IPO Stack newsletter for weekly updates.
Devoted Health is valued at $12.6B as of January 2021. This valuation is based on its most recent private funding round tracked by TechStackIPO.
Accredited investors can access Devoted Health shares through secondary market platforms, pre-IPO investment funds, and broker-dealer platforms that facilitate private company transactions. TechStackIPO's marketplace tracks available access options. Note: pre-IPO investments carry higher risk and limited liquidity compared to public market investing.
Devoted Health scores 66/100 (Grade: C) on TechStackIPO's IPO Readiness Index. The score evaluates funding scale, valuation trajectory, funding momentum, stage progression, and company maturity. Scores above 70 indicate strong near-term IPO potential.
Devoted Health has raised $2.1B in total venture capital and private equity funding, with backing from Andreessen Horowitz, T. Rowe Price, F-Prime Capital.
Devoted Health's notable investors include Andreessen Horowitz, T. Rowe Price, F-Prime Capital, Premji Invest. Full investor details, funding round history, and lead investor breakdowns are available on TechStackIPO.
Devoted Health is a Healthcare Technology company. Medicare Advantage plan combining insurance and care coordination for seniors.